Just attended the presentation. Impressive technology.
key benefits
1: Impressive In Vivo results in mice
2: good survival rates over 90 days
3: the protection from reoccurrence without additional dosage 4: the off shelf treatment from healthy donors ( big advantage compared to using the cells taken from the patients which is faster, cheaper and potential of healthier cells being used instead of compromised cells from the affected patients).
5: patents to 2038
6: develop additional products using other CAR cells.
- Forums
- ASX - By Stock
- ALA
- Ann: SUDA Licenses a Novel iNKT Cell Therapy Platform
Ann: SUDA Licenses a Novel iNKT Cell Therapy Platform, page-36
Featured News
Add ALA (ASX) to my watchlist
|
|||||
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $147.2M |
Open | High | Low | Value | Volume |
14.0¢ | 14.3¢ | 14.0¢ | $31.21K | 222.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 632125 | 14.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.5¢ | 158860 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 632125 | 0.140 |
17 | 501429 | 0.135 |
9 | 775115 | 0.130 |
9 | 451775 | 0.125 |
10 | 469187 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.145 | 148458 | 8 |
0.150 | 115719 | 4 |
0.155 | 234472 | 5 |
0.160 | 572733 | 9 |
0.165 | 152123 | 4 |
Last trade - 12.12pm 04/09/2024 (20 minute delay) ? |
Featured News
ALA (ASX) Chart |